Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 19771 / DOSAGE - TABLET;ORAL - 200MG;30MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| IBUPROFEN(UNII: WK2XYI10QM) (IBUPROFEN - UNII:WK2XYI10QM) | IBUPROFEN | 200mg |
| PSEUDOEPHEDRINE HYDROCHLORIDE(UNII: 6V9V2RYJ8N) (PSEUDOEPHEDRINE - UNII:7CUC9DDI9F) | PSEUDOEPHEDRINE HYDROCHLORIDE | 30mg |
Inactive Ingredients
| Ingredient Name | Haleon US Holdings LLC |
|---|---|
| CARNAUBA WAX(R12CBM0EIZ) | |
| CROSCARMELLOSE SODIUM(M28OL1HH48) | |
| DIACETYLATED MONOGLYCERIDES(5Z17386USF) | |
| FERRIC OXIDE RED(1K09F3G675) | |
| METHYLPARABEN(A2I8C7HI9T) | |
| MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | |
| POVIDONE, UNSPECIFIED(FZ989GH94E) | |
| PROPYLPARABEN(Z8IX2SC1OH) | |
| SHELLAC(46N107B71O) | |
| SILICON DIOXIDE(ETJ7Z6XBU4) | |
| SODIUM BENZOATE(OJ245FE5EU) | |
| SODIUM LAURYL SULFATE(368GB5141J) | |
| STARCH, CORN(O8232NY3SJ) | |
| STEARIC ACID(4ELV7Z65AP) | |
| SUCROSE(C151H8M554) | |
| TITANIUM DIOXIDE(15FIX9V2JP) |
